<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01964105</url>
  </required_header>
  <id_info>
    <org_study_id>201210065</org_study_id>
    <nct_id>NCT01964105</nct_id>
  </id_info>
  <brief_title>3D Breast Imaging for Cosmetic and Reconstructive Breast Surgery</brief_title>
  <official_title>3D Breast Imaging for Cosmetic and Reconstructive Breast Surgery: Does 3D Improve Patient Reported Outcomes in Primary Breast Augmentation?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to evaluate the impact of incorporating three-dimensional
      (3D)imaging during preoperative consultation on patient reported outcomes in primary breast
      augmentation surgery. 3D imaging is an innovative technology that allows the surgeon to share
      with images how one could look after one's procedure. The patient's assessment will be
      collected using the Breast Q, an objective questionnaire that captures patient satisfaction
      with breast augmentation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consultation for primary breast augmentation involves clear communication between patient and
      surgeon to select the implant and manage expectations. Tissue-based planning strategies rely
      on tissue characteristics and measurements to produce safe and reproducible aesthetic
      outcomes. The implementation of sizers in the preoperative consultation and a greater
      emphasis on patient aesthetic goals have also proven to be favorable strategies. Recently,
      many plastic surgeons have started to incorporate three-dimensional (3D) photography and
      computer simulation into their preoperative consultation process. The accuracy of computer
      simulation for volume assessment of breast augmentation is reportedly â‰¥90%, and patients
      demonstrate a preference for consultations involving simulation.Support for computer
      simulation, however, is not unanimous.

      Quantitative analyses, prospective study designs, and utilization of validated health-related
      quality of life metrics have been recommended to more thoroughly scrutinize implant selection
      systems and outcomes in aesthetic surgery.Mammometrics yields numerical data useful for
      quantifying changes in breast morphology after breast reduction, reconstruction with
      implants, and augmentation. The BREAST-Q represents the most comprehensive and quantitative
      method for patient self-assessment following breast surgery, and has gained traction as a
      patient-reported outcomes instrument for breast augmentation. To date, there are no studies
      that focus on the impact of simulation on patient-reported outcomes in breast augmentation,
      as measured with the validated BREAST-Q. Furthermore, there is minimal data examining
      correlations between patient-reported outcomes and mammometrics.

      The purpose of this study was to conduct a prospective, clinical trial to evaluate the impact
      of 3D imaging and simulation used during the preoperative consultation on postoperative
      patient-reported outcomes and quantitative changes in breast morphology. We hypothesized that
      computer simulation would facilitate patient education and surgical planning, thus leading to
      quantitatively higher patient-reported outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">May 16, 2017</completion_date>
  <primary_completion_date type="Actual">May 16, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Breast Q Augmentation Module</measure>
    <time_frame>up to 6 months postop visit.</time_frame>
    <description>BREAST-Q is a validated measures of patient reported outcomes (this is not an acronym). For this study we utilized the preoperative and postoperative BREAST -Q designed to analyze outcomes following breast augmentation The BREAST-Q is measured as a Q-score on a scale of 0-100. 0 is a poor score, 100 is an optimal score. Q-scores stand independently and are not combined to create a total score.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Hypomastia</condition>
  <condition>Primary Breast Augmentation</condition>
  <arm_group>
    <arm_group_label>3D Imaging Simulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention Group: 3D Image Simulation + Standard Preoperative Evaluation Goal: 50 patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Preoperative Evaluation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control Group: Patients will receive standard preoperative evaluation (2D imaging).
Goal: 50 patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Randomized Cohort: 3D Imaging</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients who refuse the option of randomization but otherwise meet the inclusion and exclusion criteria will be offered participation in this study as part of a non-randomized cohort.
Goal: 50 Patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D Imaging</intervention_name>
    <arm_group_label>3D Imaging Simulation</arm_group_label>
    <arm_group_label>Non-Randomized Cohort: 3D Imaging</arm_group_label>
    <other_name>Vectra 3D</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Scheduled for elective breast augmentation cosmetic procedure.

        Exclusion Criteria:

          -  Breast reconstruction for malignancy

          -  Cognitively unable to provide informed consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Terence M Myckatyn, MD, FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>West County Plastic Surgeons of Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://westcountyplasticsurgeons.wustl.edu/</url>
    <description>Click here for Washington University's study location.</description>
  </link>
  <reference>
    <citation>Tepper OM, Unger JG, Small KH, Feldman D, Kumar N, Choi M, Karp NS. Mammometrics: the standardization of aesthetic and reconstructive breast surgery. Plast Reconstr Surg. 2010 Jan;125(1):393-400. doi: 10.1097/PRS.0b013e3181c4966e.</citation>
    <PMID>20048631</PMID>
  </reference>
  <reference>
    <citation>Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009 Aug;124(2):345-53. doi: 10.1097/PRS.0b013e3181aee807.</citation>
    <PMID>19644246</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2013</study_first_submitted>
  <study_first_submitted_qc>October 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2013</study_first_posted>
  <results_first_submitted>October 5, 2017</results_first_submitted>
  <results_first_submitted_qc>November 29, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">December 26, 2017</results_first_posted>
  <last_update_submitted>November 29, 2017</last_update_submitted>
  <last_update_submitted_qc>November 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypomastia</keyword>
  <keyword>Augmentation</keyword>
  <keyword>Breast</keyword>
  <keyword>3D</keyword>
  <keyword>Breast Q</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Preoperative Evaluation</title>
          <description>Control Group: Patients will receive standard preoperative evaluation (2D imaging).
Goal: 50 patients</description>
        </group>
        <group group_id="P2">
          <title>Non-Randomized Cohort: 3D Imaging</title>
          <description>Patients who refuse the option of randomization but otherwise meet the inclusion and exclusion criteria will be offered participation in this study as part of a non-randomized cohort.
Goal: 50 Patients
3D Imaging</description>
        </group>
        <group group_id="P3">
          <title>3D Imaging Simulation</title>
          <description>Intervention Group: 3D Image Simulation + Standard Preoperative Evaluation Goal: 50 patients
3D Imaging</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="75"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="62"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All patients presenting for primary breast augmentation that were not excluded. We excluded patients who refused participation in a study, cancelled surgery, had greater than grade I ptosis, congenital deformity of the chest wall, could not commit to 6 months follow-up, needed a concurrent mastopexy, or had concomitant fat transfer to the breast.</population>
      <group_list>
        <group group_id="B1">
          <title>3D Imaging Simulation</title>
          <description>The intervention group underwent computer simulation with the Vectra Sculptor package (Canfield Scientific Inc, Parsippany, NJ) in addition to control group preoperative evaluation.</description>
        </group>
        <group group_id="B2">
          <title>Standard Preoperative Evaluation</title>
          <description>The control group underwent tissue-based planning that was supplemented by review of photos obtained from magazines or the internet, and placement of sizers in a surgical bra. Control group patients underwent three-dimensional photography with the same system but were not simulated.</description>
        </group>
        <group group_id="B3">
          <title>Non-Randomized Cohort: 3D Imaging</title>
          <description>Since enrollment in the non-randomized arm was predicated upon a pre-existing desire for computer simulation, all of these patients received this intervention.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="62"/>
            <count group_id="B4" value="85"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="62"/>
                    <count group_id="B4" value="85"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.3" spread="23.1"/>
                    <measurement group_id="B2" value="40.2" spread="11"/>
                    <measurement group_id="B3" value="35.8" spread="8.2"/>
                    <measurement group_id="B4" value="37.2" spread="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Female</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="62"/>
                    <count group_id="B4" value="85"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="62"/>
                    <count group_id="B4" value="85"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Volume of Breast</title>
          <units>cubic centimeters (cc)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="62"/>
                    <count group_id="B4" value="85"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="494.5" spread="93"/>
                    <measurement group_id="B2" value="503.4" spread="113.1"/>
                    <measurement group_id="B3" value="420" spread="119.3"/>
                    <measurement group_id="B4" value="441" spread="120.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BREAST-Q</title>
          <description>BREAST-Q is a validated measures of patient reported outcomes. For this study we utilized the preoperative and postoperative BREAST -Q designed to analyze outcomes following breast augmentation The BREAST-Q is measured as a Q-score on a scale of 0-100. 0 is a poor score, 100 is an optimal score.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="62"/>
                    <count group_id="B4" value="85"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.6" spread="18.6"/>
                    <measurement group_id="B2" value="70.1" spread="21.5"/>
                    <measurement group_id="B3" value="64.8" spread="19.3"/>
                    <measurement group_id="B4" value="64.6" spread="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Breast Q Augmentation Module</title>
        <description>BREAST-Q is a validated measures of patient reported outcomes (this is not an acronym). For this study we utilized the preoperative and postoperative BREAST -Q designed to analyze outcomes following breast augmentation The BREAST-Q is measured as a Q-score on a scale of 0-100. 0 is a poor score, 100 is an optimal score. Q-scores stand independently and are not combined to create a total score.</description>
        <time_frame>up to 6 months postop visit.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Preoperative Evaluation</title>
            <description>Intervention Group: 3D Image Simulation + Standard Preoperative Evaluation Goal: 50 patients
3D Imaging</description>
          </group>
          <group group_id="O2">
            <title>3D Imaging Simulation</title>
            <description>Control Group: Patients will receive standard preoperative evaluation (2D imaging).
Goal: 50 patients</description>
          </group>
          <group group_id="O3">
            <title>Non-Randomized Cohort: 3D Imaging</title>
            <description>Patients who refuse the option of randomization but otherwise meet the inclusion and exclusion criteria will be offered participation in this study as part of a non-randomized cohort.
Goal: 50 Patients
3D Imaging</description>
          </group>
        </group_list>
        <measure>
          <title>Breast Q Augmentation Module</title>
          <description>BREAST-Q is a validated measures of patient reported outcomes (this is not an acronym). For this study we utilized the preoperative and postoperative BREAST -Q designed to analyze outcomes following breast augmentation The BREAST-Q is measured as a Q-score on a scale of 0-100. 0 is a poor score, 100 is an optimal score. Q-scores stand independently and are not combined to create a total score.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="494.5" spread="93"/>
                    <measurement group_id="O2" value="503.4" spread="113.1"/>
                    <measurement group_id="O3" value="420" spread="119.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months (entire study period)</time_frame>
      <desc>Adverse events were collected as defined by clinicaltrials.gov</desc>
      <group_list>
        <group group_id="E1">
          <title>Standard Preoperative Evaluation</title>
          <description>Patients undergo standard tissue-based planning. They were randomized to this intervention.</description>
        </group>
        <group group_id="E2">
          <title>3D Imaging Simulation</title>
          <description>Patient undergo three-dimensional simulation of their breast augmentation. They were randomized to this intervention.</description>
        </group>
        <group group_id="E3">
          <title>Non-Randomized Cohort: 3D Imaging</title>
          <description>Patient undergo three-dimensional simulation of their breast augmentation. They sought this intervention (ie. not randomized).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>TERENCE MICHAEL MYCKATYN, PI, PROFESSOR, PLASTIC SURGERY</name_or_title>
      <organization>WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, SAINT LOUIS</organization>
      <phone>314-362-4263</phone>
      <email>myckatyn@wustl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

